Trial | NCT00765024  Report issue

Title

Ivermectin Versus Albendazole for Chronic Strongyloidiasis
Efficacy and Safety of Ivermectin Versus Albendazole for Chronic Strongyloidiasis

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    90
A prospective controlled trial to compare the efficacy and safety of 7-day albendazole, single dose ivermectin, and 2-single dose ivermectin in 72 patients with chronic strongyloidiasis will be conducted at Siriraj Hospital, Bangkok, Thailand.
Study Started
Jul 31
2008
Primary Completion
Apr 30
2010
Study Completion
Apr 30
2010
Last Update
Sep 07
2017

Drug Ivermectin

single dose of 200 mcg/kg

  • Other names: stromectal

Drug ivermectin

two single dose of 200mcg/kg in 2 weeks

  • Other names: stromectal

Drug Albendazole

Albendazole 7 days

Albendazole Active Comparator

Albendazole for 7 days

ivermectin Experimental

ivermectin 200 mcg/kg single dose

ivermectin 2 doses Experimental

ivermectin 200 mcg/kg two doses in 2 weeks

Criteria 

Inclusion Criteria:

Patients with positive strongyloides larva in the stool

Exclusion Criteria:

Pregnancy
Lactating women
Known allergy to any study drug
No Results Posted